warning icon

Rapport COVID-19 DEW, propulsé par Reformulary® - Lire la suite

close

Dernières nouvelles du
monde de Reformulary

Reformulary Group launches COVID-19 DEW Report
 
En savoir plus
New study underscores importance of medical cannabis rating system
 
En savoir plus
Reformulary 2019 Year in Review
 
En savoir plus
Cannabis Standard Insights, Issue #2 published by Reformulary Group
 
En savoir plus
[Anglais] CIX TOP 20 Early and CIX TOP 10 Growth announced Reformulary as a CIX TOP 20 Early, one of...
 
En savoir plus
Letter to the editor: Pharmacare – not all Canadians, not all drugs
 
En savoir plus
The challenges with medical cannabis in the workplace
 
En savoir plus
Reformulary Group creates online community platform for info on medical cannabis
 
En savoir plus
Reformulary Group launches medical cannabis formulary
 
En savoir plus
Reformulary 2018 Year in Review
 
En savoir plus
Canada’s first evidence-based medical cannabis formulary launches
 
En savoir plus
The Reformulary, now available through Great-West Life, enhances drug plan sustainability for plan s...
 
En savoir plus